Barclays
OSCR icon

Barclays’s Oscar Health OSCR Stock Holding History

Barclays’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-32,500
Closed -$426K – 5459
2025
Q1 		$426K Buy
+32,500
New +$482K ﹤0.01% 3626

Other funds holding OSCR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's OSCR Position: Q1 2026 in Review

Barclays reduced its Oscar Health (OSCR) stake by 36% in Q1 2026, selling an estimated $3.37M and leaving 427,506 shares worth $4.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1834.

Barclays first reported a position in OSCR in Q1 2022 and has held it in 17 quarters since. The position peaked at $9.58M in Q4 2025. 330 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

  • Barclays held 427,506 shares of Oscar Health worth $4.9M as of Q1 2026.
  • Barclays sold 239,238 Oscar Health shares in Q1 2026, an estimated $3.37M.
  • Oscar Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1834 holding.
  • Barclays first reported a position in Oscar Health in Q1 2022 and has held it in 17 quarters since.
  • Barclays's Oscar Health position peaked at $9.58M in Q4 2025.
  • 330 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.